SEARCH

SEARCH BY CITATION

References

  • 1
    Fontana R, Ligozzi M, Pittaluga F, Satta G. Intrinsic penicillin resistance in enterococci. Microb Drug Resist 1996; 2(2): 20913.
  • 2
    Rybkine T, Mainardi JL, Sougakoff W, Collatz E, Gutmann L. Penicillin-binding protein 5 sequence alterations in clinical isolates of Enterococcus faecium with different levels of beta-lactam resistance. J Infect Dis 1998; 178(1): 15963.
  • 3
    Patterson JE, Masecar BL, Zervos MJ. Characterization and comparison of two penicillinase-producing strains of Streptococcus (Enterococcus) faecalis. Antimicrob Agents Chemother 1988; 32(1): 1224.
  • 4
    Horodniceanu T, Bougueleret L, El-Solh N, Bieth G, Delbos F. High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes. Antimicrob Agents Chemother 1979; 16(5): 6869.
  • 5
    Mederski-Samoraj BD, Murray BE. High-level resistance to gentamicin in clinical isolates of enterococci. J Infect Dis 1983; 147(4): 7517.
  • 6
    Moellering RC Jr, Wennersten C, Medrek T, Weinberg AN. Prevalence of high-level resistance to aminoglycosides in clinical isolates of enterococci. Antimicrob Agents Chemother 1970; 10: 33540.
  • 7
    Calderwood SA, Wennersten C, Moellering RC Jr, Kunz LJ, Krogstad DJ. Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci: prevalence, evolution, and relationship to synergism with penicillin. Antimicrob Agents Chemother 1977; 12(3): 4015.
  • 8
    Zervos MJ, Kauffman CA, Therasse PM, Bergman AG, Mikesell TS, Schaberg DR. Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med 1987; 106(5): 68791.
  • 9
    Gordon S, Swenson JM, Hill BC et al. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group. J Clin Microbiol 1992; 30(9): 23738.
  • 10
    Bartoloni A, Stefani S, Orsi A, Nicoletti A, Difonzo AR, Paradisi F. High-level aminoglycoside resistance among enterococci isolated from blood cultures. J Antimicrob Chemother 1992; 29(6): 72931.
  • 11
    Lavery A, Rossney AS, Morrison D, Power A, Keane CT. Incidence and detection of multi-drug-resistant enterococci in Dublin hospitals. J Med Microbiol 1997; 46(2): 1506.
  • 12
    Tsakris A, Pournaras S, Maniatis AN, Douboyas J, Antoniadis A. Increasing prevalence of high-level gentamicin resistance among Enterococci isolated in Greece. Chemotherapy 2001; 47(2): 869.
  • 13
    Fasola EL, Moody JA, Shanholtzer CJ, Peterson LR. Bactericidal action of gentamicin against enterococci that are sensitive, or exhibit low- or high-level resistance to gentamicin. Diagn Microbiol Infect Dis 1994; 19(1): 5760.
  • 14
    Leclercq R, Dutka-Malen S, Brisson-Noel A et al. Resistance of enterococci to aminoglycosides and glycopeptides. Clin Infect Dis 1992; 15(3): 495501.
  • 15
    Eliopoulos GM, Farber BF, Murray BE, Wennersten C, Moellering RC Jr. Ribosomal resistance of clinical enterococcal isolates to streptomycin. Antimicrob Agents Chemother 1984; 25(3): 3989.
  • 16
    Hancock RE. Aminoglycoside uptake and mode of action—with special reference to streptomycin and gentamicin. I. Antagonists and mutants. J Antimicrob Chemother 1981; 8(4): 24976.
  • 17
    Standiford HD, De Maine JB, Kirby WM. Antibiotic synergism of enterococci. Relation to inhibitory concentrations. Arch Intern Med 1970; 126(2): 2559.
  • 18
    Van Den Braak N, Van Belkum A, Kreft D, Te Witt R, Verbrugh HA, Endtz HP. The prevalence and clonal expansion of high-level gentamicin-resistant enterococci isolated from blood cultures in a Dutch university hospital. J Antimicrob Chemother 1999; 44(6): 7958.
  • 19
    Hirji K, Stsiatis A, Metha C. Median unibased estimation for binary data. Am Statistician 1999; 43: 711.
  • 20
    CYTEL Software Corporation. Logxact 4 for Windows. User manual. Cambridge, MA: CYTEL Software Corporation, 2000.
  • 21
    Facklam RR, Sahmo DF, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. Enterococcus. Washington, DC: American Society for Microbiology, 1995.
  • 22
    Ericsson HM, Sherris JC. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand [B] Microbiol Immunol 1971; 217(suppl 217): 1+.
  • 23
    Bergan T, Bruun JN, Digranes A, Lingaas E, Melby KK, Sander J. Susceptibility testing of bacteria and fungi. Report from the Norwegian Working Group on Antibiotics. Scand J Infect Dis Suppl 1997; 103: 136.
  • 24
    Murray BE, Singh KV, Heath JD, Sharma BR, Weinstock GM. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 1990; 28(9): 205963.
  • 25
    Dahl KH, Simonsen GS, Olsvik O, Sundsfjord A. Heterogeneity in the vanB gene cluster of genomically diverse clinical strains of vancomycin-resistant enterococci. Antimicrob Agents Chemother 1999; 43(5): 110510.
  • 26
    Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33(9): 22339.
  • 27
    Van Asselt GJ, Vliegenthart JS, Petit PL, Van De Klundert JA, Mouton RP. High-level aminoglycoside resistance among enterococci and group A streptococci. J Antimicrob Chemother 1992; 30(5): 6519.
  • 28
    Melhus A, Tjernberg I. First documented isolation of vancomycin-resistant Enterococcus faecium in Sweden. Scand J Infect Dis 1996; 28(2): 1913.
  • 29
    Kjerulf A, Pallesen L, Westh H. Vancomycin-resistant enterococci at a large university hospital in Denmark. Apmis 1996; 104(6): 4759.
  • 30
    Torell E, Fredlund H, Tornquist E, Myhre EB, Sjoberg L, Sundsfjord A. Intrahospital spread of vancomycin-resistant Enterococcus faecium in Sweden. Scand J Infect Dis 1997; 29(3): 25963.
  • 31
    Harthug S, Digranes A, Hope O, Kristiansen BE, Allum AG, Langeland N. Vancomycin resistance emerging in a clonal outbreak caused by ampicillin-resistant Enterococcus faecium. Clin Microbiol Infect 2000; 6(1): 1928.
  • 32
    Torfoss D, Aukrust P, Brinch L et al. Carrier rate of resistant enterococci in a tertiary care hospital in Norway. Apmis 1999; 107(6): 5459.
  • 33
    Wade JJ. Enterococcus faecium in hospitals. Eur J Clin Microbiol Infect Dis 1997; 16(2): 11319.
  • 34
    Zervos MJ, Dembinski S, Mikesell T, Schaberg DR. High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection. J Infect Dis 1986; 153(6): 107583.
  • 35
    Simjee S, Manzoor SE, Fraise AP, Gill MJ. Nature of transposon-mediated high-level gentamicin resistance in Enterococcus faecalis isolated in the United Kingdom. J Antimicrob Chemother 2000; 45(5): 56575.
  • 36
    Patterson JE, Sweeney AH, Simms M et al. An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. Medicine (Baltimore) 1995; 74(4): 191200.
  • 37
    Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore) 1988; 67(4): 24869.
  • 38
    Watanakunakorn C, Burkert T. Infective endocarditis at a large community teaching hospital, 1980–90. A review of 210 episodes. Medicine (Baltimore) 1993; 72(2): 90102.
  • 39
    Wells VD, Wong ES, Murray BE, Coudron PE, Williams DS, Markowitz SM. Infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis. Ann Intern Med 1992; 116(4): 28592.
  • 40
    Gray JW, Pedler SJ. Antibiotic-resistant enterococci. J Hosp Infect 1992; 21(1): 114.
  • 41
    Handwerger S, Raucher B, Altarac D et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993; 16(6): 7505.
  • 42
    Viagappan M, Holliman RE. Risk factors for acquisition of gentamicin-resistant enterococcal infection: a case-controlled study. Postgrad Med J 1999; 75(884): 3425.
  • 43
    World Health Organization. Oslo: Legemiddelforbruket i Norge 1996–2000. WHO Collaborating Centre for Drug Statistics Methodology, 2000.
  • 44
    Axelrod P, Talbot GH. Risk factors for acquisition of gentamicin-resistant enterococci. A multivariate analysis. Arch Intern Med 1989; 149(6): 1397401.